ARVN
Price
$32.68
Change
+$0.57 (+1.78%)
Updated
May 17, 6:59 PM EST
80 days until earnings call
NRIX
Price
$16.59
Change
+$1.19 (+7.73%)
Updated
May 17, 6:59 PM EST
53 days until earnings call
Ad is loading...

ARVN vs NRIX

Header iconARVN vs NRIX Comparison
Open Charts ARVN vs NRIXBanner chart's image
Arvinas
Price$32.68
Change+$0.57 (+1.78%)
Volume$292.5K
CapitalizationN/A
Nurix Therapeutics
Price$16.59
Change+$1.19 (+7.73%)
Volume$2.61M
CapitalizationN/A
View a ticker or compare two or three
ARVN vs NRIX Comparison Chart

Loading...

ARVNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NRIXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ARVN vs. NRIX commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Buy and NRIX is a StrongBuy.

COMPARISON
Comparison
May 19, 2024
Stock price -- (ARVN: $32.68 vs. NRIX: $16.59)
Brand notoriety: ARVN and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 76% vs. NRIX: 262%
Market capitalization -- ARVN: $2.24B vs. NRIX: $1.01B
ARVN [@Biotechnology] is valued at $2.24B. NRIX’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARVN and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 5 bullish, 3 bearish.
  • NRIX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than NRIX.

Price Growth

ARVN (@Biotechnology) experienced а +3.94% price change this week, while NRIX (@Biotechnology) price change was +22.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

ARVN is expected to report earnings on Aug 06, 2024.

NRIX is expected to report earnings on Jul 10, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ARVN with price predictions.
OPEN
A.I.dvisor published
a Summary for NRIX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ARVN($2.24B) has a higher market cap than NRIX($1.01B). NRIX YTD gains are higher at: 60.756 vs. ARVN (-20.603).
ARVNNRIXARVN / NRIX
Capitalization2.24B1.01B221%
EBITDAN/AN/A-
Gain YTD-20.60360.756-34%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ARVNNRIX
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 27 days ago
84%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ARVNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NRIXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFYCX10.510.05
+0.48%
Hartford Schroders Intl Multi-Cp Val C
PQSAX24.330.03
+0.12%
Virtus KAR Small-Cap Value A
DIVPX15.370.01
+0.07%
MAI Managed Volatility Investor
TIBCX25.660.01
+0.04%
Thornburg Investment Income Builder C
GWSCX13.52N/A
N/A
Gabelli Focused Gr and Inc C

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with NTLA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+7.73%
NTLA - NRIX
53%
Loosely correlated
+0.19%
BEAM - NRIX
52%
Loosely correlated
+3.49%
PRME - NRIX
48%
Loosely correlated
+0.57%
ARVN - NRIX
48%
Loosely correlated
+1.78%
ALEC - NRIX
48%
Loosely correlated
-0.91%
More